|
市場調查報告書
關於冠狀動脈疾病診斷與治療的新技術：2007年
Emerging Technologies for the Diagnosis and Treatment of Coronary Artery Disease 2007
|
關於冠狀動脈疾病診斷與治療的新技術：2007年 是由出版商Millennium Research Group在2007年09月所出版的。
這份英文市場調查報告書價格從美金4197起跳。
冠狀動脈疾病是先進國家的主要死因。因此冠狀動脈疾病成為醫療研究最前線的研究領域。
此報告書的內容涵蓋有冠狀動脈疾病的概要、影像診斷裝置、血管再生裝置、血管新生療法的各種技術概要與市場潛力、競爭分析等。報告書之內容摘要如下所示。
摘要
方法論
第1章 所謂冠狀動脈疾病是
- 說明
- 冠狀動脈疾病概要
- 疫學
- 冠狀動脈疾病的既有診斷與治療的選擇項目
- 未來展望
第2章 冠狀動脈疾病的影像診斷裝置
- 概說
- 血管內超音波法
- 不安定凝血因子診斷
- 技術概要
- 電腦斷層攝影（CT）
- 磁共振影像法（MRI）
- 近紅外線分光法（NIRS）
- 光學干涉斷層掃描（OCT）
- 溫度分佈影像法
- 市場潛力
- 競爭分析
- 電腦斷層攝影（CT）
- 磁共振影像法（MRI）
- 近紅外線分光法（NIRS）
- 光學干涉斷層掃描（OCT）
- 溫度分佈影像法
第3章 冠狀動脈疾病的血管再生裝置
- 概說
- 新支架技術
- 技術概要
- 市場潛力
- 生體吸收性支架
- 特殊塗層藥劑溶出支架
- 全體冠狀動脈支架市場
- 競爭分析
- 人工血管
- 遠距操作技術
第4章 冠狀動脈疾病的血管新生療法
附錄
Abstract
Coronary artery disease is a leading cause of death in the developed world
and, as such, is at the forefront of medical research.
Table of Contents
TABLE OF CONTENTS
LIST OF EXHIBITS
EXECUTIVE SUMMARY
METHODOLOGY
1.0 CORONARY ARTERY DISEASE
- 1.1 Introduction
- 1.2 An Overview of Coronary Artery Disease
- 1.3 Epidemiology
- 1.4 Existing Diagnosis and Treatment Options for Coronary Artery Disease
- 1.4.1 Diagnosis
- 1.4.2 Treatment
- 1.5 Future Outlook
2.0 DIAGNOSTIC IMAGING DEVICES
- 2.1 Overview
- 2.2 Intravascular Ultrasound
- 2.2.1 Technology Overview
- 2.2.2 Market Potential
- 2.2.3 Competitor Insights
- 2.3 Vulnerable Plaque Diagnosis
- 2.3.1 Technology Overview
- 2.3.1.1 Computed Tomography
- 2.3.1.2 Magnetic Resonance Imaging
- 2.3.1.3 Near-Infrared Spectroscopy
- 2.3.1.4 Optical Coherence Tomography
- 2.3.1.5 Thermography
- 2.3.2 Market Potential
- 2.3.3 Competitor Insights
- 2.3.3.1 Computed Tomography
- 2.3.3.2 Magnetic Resonance Imaging
- 2.3.3.3 Near-Infrared Spectroscopy
- 2.3.3.4 Optical Coherence Tomography
- 2.3.3.5 Thermography
3.0 REVASCULARIZATION DEVICES
- 3.1 Overview
- 3.2 Novel Stent Technologies
- 3.2.1 Technology Overview
- 3.2.1.1 Bioabsorbable Stents
- 3.2.1.2 Specially Coated Drug-Eluting Stents
- 3.2.2 Market Potential
- 3.2.2.1 Bioabsorbable Stents
- 3.2.2.2 Specially Coated Drug-Eluting Stents
- 3.2.2.3 Overall Coronary Stent Market
- 3.2.3 Competitor Insights
- 3.2.3.1 Bioabsorbable Stents
- 3.2.3.2 Specially Coated Drug-Eluting Stents
- 3.3 Synthetic Grafts
- 3.3.1 Technology Overview
- 3.3.2 Market Potential
- 3.3.3 Competitor Insights
- 3.4 Remote Navigation Technologies
- 3.4.1 Technology Overview
- 3.4.2 Market Potential
- 3.4.3 Competitor Insights
4.0 NEOVASCULARIZATION THERAPIES
- 4.1 Overview
- 4.2 Therapeutic Angiogenesis
- 4.2.1 Technology Overview
- 4.2.1.1 Gene Therapy
- 4.2.1.2 Stem Cell Therapy
- 4.2.2 Market Potential
- 4.2.3 Competitor Insights
- 4.2.3.1 Gene Therapy
- 4.2.3.2 Stem Cell Therapy
APPENDIX A: MRG ACRONYMS AND INITIALISMS
APPENDIX B: ADDITIONAL COMPETITOR INFORMATION
List of Exhibits
EXECUTIVE SUMMARY
- Exhibit 1: New Imaging Technology Procedures, US, 2009-2018
- Exhibit 2: PCIs, by Type, US, 2018
- Exhibit 3: Therapeutic Angiogenesis Procedures, US, 2013-2018
CHAPTER 1: CORONARY ARTERY DISEASE
- Exhibit 4: Frequently Used CAD Terminology
- Exhibit 5: Stages of Lesion Development
- Exhibit 6: Common CAD Risk Factors
- Exhibit 7: Global Life Expectancy, 2006
- Exhibit 8: CAD Incidence, by Region, 2007-2013 (Tabular Format)
- Exhibit 9: Symptoms of CAD
- Exhibit 10: CAD Treatment Options
CHAPTER 2: DIAGNOSTIC IMAGING DEVICES
- Exhibit 11: IVUS Procedures, by Region, 2006-2011
- Exhibit 12: New Imaging Technology Penetration, as a % of Total, US,
2009-2018
- Exhibit 13: New Imaging Technology Penetration, US, 2009-2018
CHAPTER 3: REVASCULARIZATION DEVICES
- Exhibit 14: BAS Procedures, US, 2012-2018
- Exhibit 15: BAS Penetration, US, 2012-2018
- Exhibit 16: SCDES Procedures, US, 2010-2018
- Exhibit 17: SCDES Penetration, US, 2010-2018
- Exhibit 18: PCIs, by Type, as a % of Total, US, 2008-2018
- Exhibit 19: PCIs, by Type, US, 2008-2018
- Exhibit 20: PCI Growth, by Type, US, 2008-2018
- Exhibit 21: BAS in Development, 2007
- Exhibit 22: BAS Material Absorption Time
- Exhibit 23: Polymer-Free and Bioabsorbable Polymer-Coated Stents, 2007
- Exhibit 24: Synthetic Graft Procedures, 2011-2018
- Exhibit 25: Synthetic Graft Penetration, 2011-2018
- Exhibit 26: RNT Procedures, 2008-2018
- Exhibit 27: RNT Penetration, US, 2008-2018
CHAPTER 4: NEOVASCULARIZATION THERAPIES
- Exhibit 28: Therapeutic Angiogenesis Procedures, US, 2013-2018
- Exhibit 29: Therapeutic Angiogenesis Procedure Penetration, US, 2013-2018
APPENDIX A: MRG ACRONYMS AND INITIALISMS
APPENDIX B: ADDITIONAL COMPETITOR INFORMATION
|
